Fibrosis biomarkers in isolated Raynaud's phenomenon: too little, too soon?

Ann Rheum Dis 2014 May 16;73(5):940-1. Epub 2013 Dec 16.

Department of Clinical Science & Community Health, Division of Rheumatology, Istituto Gaetano Pini, University of Milano, , Milano, Italy.

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2013-204009DOI Listing
May 2014
12 Reads

Publication Analysis

Top Keywords

isolated raynaud's
4
biomarkers isolated
4
phenomenon soon?
4
raynaud's phenomenon
4
fibrosis biomarkers
4
soon?
1
raynaud's
1
isolated
1
fibrosis
1
phenomenon
1

References

(Supplied by CrossRef)
Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls
Young-Min et al.
Ann Rheum Dis 2001
The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis
Abignano et al.
Ann Rheum Dis 2013
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
LeRoy et al.
J Rheumatol 1988
Raynaud's phenomenon: a proposal for classification
LeRoy et al.
Clin Exp Rheumatol 1992

Similar Publications